Terumo Corporation provided consolidated earnings guidance for the fiscal year ending March 31, 2023. The company expects net sales to be JPY 775,000 million, Operating profit to be JPY 132,000 million, profit attributable to owners of parent to be JPY 100,000 million or JPY 133.88 per basic share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,627 JPY | +0.90% | -1.35% | +13.67% |
Apr. 12 | Penumbra, Inc. : The underdog in healthcare | |
Mar. 18 | Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.67% | 25.02B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+3.43% | 26.53B | |
-0.32% | 24.96B | |
+5.22% | 22.86B |
- Stock Market
- Equities
- 4543 Stock
- News Terumo Corporation
- Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023